col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


34 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Molecular Biotechnology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Feb―22 An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine Antigen Sanaz Majidi, Khosrow Aghaiypour Kolyani, Meisam Akrami, Maryam Dadar
2 [GO] 2025―Jan―09 A Bibliometric Analysis on Multi-epitope Vaccine Development Against SARS-CoV-2: Current Status, Development, and Future Directions Kanwal Khalid, Fiaz Ahmad, Ayaz Anwar, Seng-Kai Ong
3 [GO] 2024―Nov―27 Mapping the Potential Genes and Associated Pathways Involved in Long COVID-Associated Brain Fog Using Integrative Bioinformatics and Systems Biology Strategy Chiranjib Chakraborty, Manojit Bhattacharya, Abdulrahman Alshammari, Norah A. Albekairi, Sang-Soo Lee
4 [GO] 2024―Okt―07 Exploring Niclosamide as a Multi-target Drug Against SARS-CoV-2: Molecular Dynamics Simulation Studies on Host and Viral Proteins Prachi Jagtap, Virendra Kumar Meena, Susmit Sambhare, Atanu Basu, Priya Abraham, Sarah Cherian
5 [GO] 2024―Okt―01 Glycoprofile Comparison of the SARS-CoV-2 Spike Proteins Expressed in CHO and HEK Cell Lines Helen L. Wright, Caroline Evans, Philip J. Jackson, David C. James, Kang Lan Tee, Tuck Seng Wong, et al. (+2)
6 [GO] 2024―Sep―24 Development and Validation of a Highly Sensitive RT-qLAMP Assay for Rapid Detection of SARS-CoV-2: Methodological Aspects Faezeh Mahmoudi, Davod Jafari, Seyedeh Mona Mousavi Esfahani, Arshad Hoseini, Mahmood Barati, Neda Saraygord-Afshari
7 [GO] 2024―Sep―13 Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection Nurshamimi Nor Rashid, Lina Amrani, Abdullah Alwan, Zulqarnain Mohamed, Rohana Yusof, Hussin Rothan
8 [GO] 2024―Aug―23 In Silico Analysis of Calotropis procera-Derived Phytochemicals Targeting 3CL Proteoase of SARS-CoV-2 Tayyaba Shafique, Mohsin Javed, Muhammad Ali, Shahid Iqbal, Muhammad Faizan, Ammar Zidan, et al. (+5)
9 [GO] 2024―Aug―01 Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic Thamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, Solayappan Maheswaran
10 [GO] 2024―Mai―04 Emerging Trends of Gold Nanostructures for Point-of-Care Biosensor-Based Detection of COVID-19 Akhilesh Kumar Yadav, Nagaraj Basavegowda, Saba Shirin, Shiji Raju, Rajkumar Sekar, Prathap Somu, et al. (+2)
11 [GO] 2024―Apr―25 Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain Gamze Kılıç, Elif Demirkan, Fatıma Yücel
12 [GO] 2024―Apr―15 Prediction of Prospective Mutational Landscape of SARS-CoV-2 Spike ssRNA and Evolutionary Basis of Its Host Interaction Aniket Sarkar, Trijit Arka Ghosh, Bidyut Bandyopadhyay, Smarajit Maiti, Anindya Sundar Panja
13 [GO] 2024―Mrz―08 Association Between Altered Microbiota Composition and Immune System-Related Genes in COVID-19 Infection Sara Ahmadi Badi, Arian Kariman, Ahmad Bereimipour, Shima Shojaie, Mohammadreza Aghsadeghi, Shohreh Khatami, Andrea Masotti
14 [GO] 2023―Nov―25 Immunogenicity and Protective Efficacy of Nucleic Acid-Based Vaccines Against COVID-19: A Systematic Review Dahiru Hafiz Karofi, Nafi’u Lawal, Muhammad Bashir Bello, Mustapha Umar Imam
15 [GO] 2023―Okt―25 Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend Mohammad Sharifur Rahman, Mohammad Salim Hossain
16 [GO] 2023―Jul―25 Screening of Potential Inhibitors Targeting the Main Protease Structure of SARS-CoV-2 via Molecular Docking, and Approach with Molecular Dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA Aluísio Marques da Fonseca, Bernardino Joaquim Caluaco, Junilson Martinho Canjanja Madureira, Sadrack Queque Cabongo, Eduardo Menezes Gaieta, Faustino Djata, et al. (+6)
17 [GO] 2023―Apr―19 Development of Adenovirus-Based Covid-19 Vaccine Candidate in Indonesia Anita Artarini, Tia Hadianti, Ernawati Arifin Giri-Rachman, Marselina Irasonia Tan, Intan A. Safitri, Nurhamidah A. Hidayat, et al. (+2)
18 [GO] 2023―Apr―15 Development of a Single-Chain Fragment Variable that Binds to the SARS-CoV-2 Spike Protein Produced by Genetically Modified Lactic Acid Bacteria Suzuka Oshima, Fu Namai, Takashi Sato, Takeshi Shimosato
19 [GO] 2023―Feb―13 Anticancer and Biological Effects of Some Natural Compounds and Theoretical Investigation of them Against RdRP of SARS-COV-2: In Silico and In Vitro Studies Jing Zhang, Jingyu Feng, Yang Li, Jiguo Wang, Panyan Mo, Changguo Luo
20 [GO] 2023―Feb―08 Identification of Pyrazole Derivatives of Usnic Acid as Novel Inhibitor of SARS-CoV-2 Main Protease Through Virtual Screening Approaches Miah Roney, Gagandeep Singh, A. K. M. Moyeenul Huq, Md Shaekh Forid, Wan Maznah Binti Wan Ishak, Kamal Rullah, et al. (+2)
21 [GO] 2023―Jan―24 Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study Amgad M. Rabie, Wafa A. Eltayb
22 [GO] 2022―Dez―04 Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets, and Structure-Based Druggability Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, Srijan Chatterjee, Govindasamy Agoramoorthy, Sang-Soo Lee
23 [GO] 2022―Okt―01 CRISPR-Based Diagnostics and Microfluidics for COVID-19 Point-of-Care Testing: A Review of Main Applications Fatemeh Nafian, Simin Nafian, Babak Kamali Doust Azad, Mehrdad Hashemi
24 [GO] 2022―Sep―14 Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay Termsak Tantiwiwat, Apisitt Thaiprayoon, Ake-kavitch Siriatcharanon, Chakrit Tachaapaikoon, Nongluk Plongthongkum, Dujduan Waraho-Zhmayev
25 [GO] 2022―Feb―01 The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing Zeinab Yousefi Najafabadi, Songwe Fanuel, Reza Falak, Saeed Kaboli, Gholam Ali Kardar
26 [GO] 2022―Jan―04 Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach Manojit Bhattacharya, Ashish Ranjan Sharma, Pratik Ghosh, Prasanta Patra, Bidhan Chandra Patra, Sang-Soo Lee, Chiranjib Chakraborty
27 [GO] 2021―Okt―16 An Insight Into Detection Pathways/Biosensors of Highly Infectious Coronaviruses Mehrnaz Entesari, Mina Zamani, Mohammad Heidarizadeh, Rasoul Moradi, Fatemeh Khakdan, Fariba Rafiei
28 [GO] 2021―Aug―22 Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors Rimanshee Arya, Vishal Prashar, Mukesh Kumar
29 [GO] 2021―Aug―10 Correction to: Computational Lock and Key and Dynamic Trajectory Analysis of Natural Biophors Against COVID-19 Spike Protein to Identify Effective Lead Molecules Irfan Navabshan, Balasubramaniyan Sakthivel, Rajesh Pandiyan, Mariya Gover Antoniraj, Selvakumar Dharmaraj, Veeramuthu Ashokkumar, et al. (+4)
30 [GO] 2021―Jul―25 Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System Takeru Ebihara, Akitsu Masuda, Daisuke Takahashi, Masato Hino, Hiroaki Mon, Kohei Kakino, et al. (+5)
31 [GO] 2021―Jun―22 Computational Lock and Key and Dynamic Trajectory Analysis of Natural Biophors Against COVID-19 Spike Protein to Identify Effective Lead Molecules Irfan Navabshan, Balasubramaniyan Sakthivel, Rajesh Pandiyan, Mariya Gover Antoniraj, Selvakumar Dharmaraj, Veeramuthu Ashokkumar, et al. (+4)
32 [GO] 2021―Jun―18 COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era Ender Volkan
33 [GO] 2021―Feb―24 Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19 Seyed Mehdi Sadat, Mohammad Reza Aghadadeghi, Masoume Yousefi, Arezoo Khodaei, Mona Sadat Larijani, Golnaz Bahramali
34 [GO] 2021―Jan―19 Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro) Hussin A. Rothan, Teow Chong Teoh
 [1] 

34 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec